514854-13-8

Basic information

• Product Name: 6-Ethyl-5-iodopyriMidine-2,4-diaMine
• Synonyms: 6-Ethyl-5-iodopyriMidine-2,4-diaMine;2,4-Diamino-6-ethyl-5-iodopyrimidine, 2,4-Diamino-6-ethyl-5-iodo-1,3-diazine
• CAS NO: 514854-13-8
• Molecular Formula: C₆H₉IN₄
• Molecular Weight: 264.06693
• Mol File: 514854-13-8.mol
• Article Data: 4

Chemical Properties

• Boiling Point: 431.3±55.0 °C(Predicted)
• Appearance: /
• Density: 1.951±0.06 g/cm3(Predicted)
• Storage Temp.: under inert gas (nitrogen or Argon) at 2–8 °C
• PKA: 6.26±0.10(Predicted)
• CAS DataBase Reference: 6-Ethyl-5-iodopyriMidine-2,4-diaMine(CAS DataBase Reference)
• NIST Chemistry Reference: 6-Ethyl-5-iodopyriMidine-2,4-diaMine(514854-13-8)
• EPA Substance Registry System: 6-Ethyl-5-iodopyriMidine-2,4-diaMine(514854-13-8)

Safety Data

• Hazardous Substances Data: 514854-13-8(Hazardous Substances Data)

Usage

General Description

6-Ethyl-5-iodopyrimidine-2,4-diamine is a chemical compound with the molecular formula C7H10N4I. It is a derivative of pyrimidine, which is a heterocyclic aromatic organic compound. This chemical is commonly used as an intermediate in the synthesis of pharmaceuticals and agrochemicals. Its structure makes it suitable for various applications in the field of organic synthesis, particularly in the development of new drugs and crop protection products. Additionally, its unique properties make it a valuable building block for the creation of novel compounds with potential medicinal and agricultural uses.

Upstream product

• 5734-67-8 2-amino-4-chloro-6-ethylpyrimidine 
• 5734-66-7 6-ethylisocytosine 
• 514854-12-7 2,4-diamino-6-ethylpyrimidine 

Relevant articles and documents

Method for synthesizing alkyne through catalytic asymmetric cross coupling (by machine translation)

The invention belongs to the field of, asymmetric synthesis, and discloses a method for catalyzing asymmetric cross- coupling to synthesize: an alkyne, and the L method comprises, the following steps, of A: preparing B a cuprous, salt and C a: ligand; preparing a catalyst; adding a base; reacting the compound with the compound with the compound; and reacting the compound with the compound. Of these, one of them, X is selected from the group consisting of, R halogens. 1 Optionally substituted heteroarylsulfonylcyanamide groups selected from the, group consisting, of optionally substituted, phenyl groups In-flight vehicle, R6 Trialkyl silyl groups or alkyl radicals, R2 Cycloalkyl radicals optionally substituted with an, optionally substituted alkyl, (CH radical2 )n R4 Multi,layer chain, n＝0-10,R saw blade4 A group selected, from, the group consisting of phenyl, alkenyl, aralkynyls, noonyloxy,and, noonylsulfonylsulfonylsulfonylsulfonylsulfonylsulfonylsulfonylsulfonylsulfonylsulphonylsulphonylsulphonylsulphonylsulphonylsulphonylsulphonylsulphonylsulphonylsulphonylphenyl disiloxy-radicals. R3 A ligand, selected from hydrogen or any of the functional groups, is selected from the group consisting of, hydrogen and any L other functional group. The method, R disclosed by the, A invention has the, advantages of good catalytic, R ’ effect, wide application range. and high catalytic efficiency, and the, method disclosed by the, invention has the. advantages of good catalytic effect, wide application range and high catalytic efficiency. (by machine translation)

Design, synthesis and biological evaluation of renin inhibitors guided by simulated annealing of chemical potential simulations

We have applied simulated annealing of chemical potential (SACP) to a diverse set of ～150 very small molecules to provide insights into new interactions in the binding pocket of human renin, a historically difficult target for which to find low molecular